HER2 Mutation Status in Japanese HER2-negative Breast Cancer Patients.

CONCLUSIONS: Better knowledge of human epidermal growth factor receptor 2 mutation status will help us to choose personalized molecular targeted therapy for use in human epidermal growth factor receptor 2-negative Japanese breast cancer patients. PMID: 24803549 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24803549?dopt=Abstract

Source: Clinical Breast Cancer - May 5, 2014 Category: Cancer & Oncology Authors: Endo Y, Dong Y, Yoshimoto N, Asano T, Hato Y, Yamashita H, Sato S, Takahashi S, Fujii Y, Toyama T Tags: Jpn J Clin Oncol Source Type: research